Continuously Improving Ifosfamide/Mesna: A Winning Combination

被引:16
作者
Anderson, Peter [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA
关键词
ETOPOSIDE; INFUSION; SARCOMAS;
D O I
10.1002/pbc.22652
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:599 / 600
页数:2
相关论文
共 11 条
[1]
Anderson Pete, 2008, Cancer Control, V15, P38
[2]
CORIAT R, CANC CHEMOTHER PHARM, V65, P491
[3]
Goorin AM, 2002, J CLIN ONCOL, V20, P426, DOI 10.1200/JCO.20.2.426
[4]
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites [J].
Kerbusch, T ;
de Kraker, J ;
Keizer, HJ ;
van Putten, JWG ;
Groen, HJM ;
Jansen, RLH ;
Schellens, JHM ;
Beijnen, JH .
CLINICAL PHARMACOKINETICS, 2001, 40 (01) :41-62
[5]
IFOSFAMIDE WITH MESNA UROPROTECTION AND ETOPOSIDE - AN EFFECTIVE REGIMEN IN THE TREATMENT OF RECURRENT SARCOMAS AND OTHER TUMORS OF CHILDREN AND YOUNG-ADULTS [J].
MISER, JS ;
KINSELLA, TJ ;
TRICHE, TJ ;
TSOKOS, M ;
JAROSINSKI, P ;
FORQUER, R ;
WESLEY, R ;
MAGRATH, I .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) :1191-1198
[6]
Priston MJ, 1998, J ONCOL PHARM PRACT, V4, P143
[7]
THE STABILITY OF IFOSFAMIDE IN AQUEOUS-SOLUTION AND ITS SUITABILITY FOR CONTINUOUS 7-DAY INFUSION BY AMBULATORY PUMP (REPRINTED FROM CANC CHEMOTHER PHARMACOL, VOL 26, PGS 144-146, 1990) [J].
RADFORD, JA ;
MARGISON, JM ;
SWINDELL, R ;
LIND, MJ ;
WILKINSON, PM ;
THATCHER, N .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1991, 117 :S154-S156
[8]
SKUBITZ KM, 1993, CANCER, V72, P2963, DOI 10.1002/1097-0142(19931115)72:10<2963::AID-CNCR2820721017>3.0.CO
[9]
2-W
[10]
Does ifosfamide affect gonadal function? [J].
Williams, Denise ;
Crofton, P. M. ;
Levitt, Gill .
PEDIATRIC BLOOD & CANCER, 2008, 50 (02) :347-351